Aureka Biotechnologies closes $100 million Series B to expand AI drug discovery models

Verifying

verifying reliability

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Aureka Biotechnologies closes $100 million Series B to expand AI drug discovery models - CoinPost Terminal